Increasing Evidence for the Utility of Red‐Light Therapy and High Concentration Atropine in Myopia Control
Clinical & Experimental Ophthalmology · 2026-07 · 54 (5) · 603-604
DOI: 10.1111/ceo.70136 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical & Experimental Ophthalmology, online erschienen am 07.07.2026. Verfasst von Gareth Lingham und 1 weiteren Autor:innen. Beteiligte Einrichtung: Lions Eye Institute, Perth, Australia. Die Arbeit nennt 11 Literaturangaben. Gefördert von: Stan Perron Charitable Foundation, Glaucoma Australia, PYC Therapeutics.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Lions Eye Institute, Perth, Australia.
- Centre for Ophthalmology and Visual Science, University of Western Australia, Perth, Australia.
- Centre for Eye Research Ireland, Sustainability and Health Research Hub, Technological University Dublin, Dublin, Ireland.
- Centre for Eye Research Australia, Melbourne, Australia.
ORCID-Profile: Gareth Lingham, David A Mackey
Förderung
- Stan Perron Charitable Foundation
- Glaucoma Australia
- PYC Therapeutics
- Channel 7 Telethon Trust
- Western Australian Future Health and Innovation Fund, Government of Western Australia
- Ocumetra
Zitieren
APA
Lingham, G., & Mackey, D. A. (2026). Increasing Evidence for the Utility of Red‐Light Therapy and High Concentration Atropine in Myopia Control. Clinical & Experimental Ophthalmology, 54(5), 603-604. https://doi.org/10.1111/ceo.70136
Vancouver
Lingham G, Mackey DA. Increasing Evidence for the Utility of Red‐Light Therapy and High Concentration Atropine in Myopia Control. Clinical & Experimental Ophthalmology. 2026;54(5):603-604. doi:10.1111/ceo.70136
BibTeX
@article{Lingham2026,
author = {Lingham, Gareth and Mackey, David A},
title = {Increasing Evidence for the Utility of Red‐Light Therapy and High Concentration Atropine in Myopia Control},
journal = {Clinical & Experimental Ophthalmology},
year = {2026},
volume = {54},
number = {5},
pages = {603--604},
doi = {10.1111/ceo.70136}
}
EUVIMED